virus-host chimera DNA
Showing 1 - 25 of >10,000
Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial
Not yet recruiting
- Hepatocellular Carcinoma
- +3 more
- (no location specified)
Feb 21, 2023
Cell-free DNA From Junction of Hepatitis B Virus Integration in
Active, not recruiting
- Hepatocellular Carcinoma
-
Taipei, TaiwanNational Taiwan University Hospital
Apr 10, 2023
Protein Biomarkers in Neonatal Herpes Simplex Virus Infection
Completed
- Neonatal Herpes Simplex Infection
- +7 more
-
Copenhagen, Denmark
- +1 more
Dec 25, 2022
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
Not yet recruiting
- Warts
- Detection of expression of SOCS3 gene
- +2 more
- (no location specified)
Mar 12, 2023
Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ
Not yet recruiting
- Cytomegalovirus Infections
- Solid Organ Transplantation
-
Bordeaux, France
- +6 more
Jan 17, 2023
es to Dissect Human Host-pathogen Interactions in Amazonian
Not yet recruiting
- Host-Pathogen Interactions
- (no location specified)
Jul 31, 2023
Netherlands Cohort Study on Acute HIV Infection
Recruiting
- Acute HIV Infection
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Feb 6, 2023
Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)
Recruiting
- Malignant Tumor
- Oncolytic Virus SDJ001
- Oncolytic Virus YD06-1
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 6, 2023
Respiratory Virus Testing and Home Spirometry for Screening of
Recruiting
- Bronchiolitis Obliterans Syndrome
- Hematopoietic and Lymphoid Cell Neoplasm
- Biospecimen Collection
- +2 more
-
Palo Alto, California
- +3 more
Aug 1, 2022
Host RNA Profiles to Detect Infections in Young Infants
Completed
- Bacterial Infections
- +7 more
-
Copenhagen, Denmark
- +3 more
Dec 25, 2022
Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)
Not yet recruiting
- Chronic Hepatitis b
- Anti-PD-1 Antibody
- Anti-PD-1 antibody
- NAs
-
Chongqing, Chongqing, ChinaThe 2nd affiliated Hospital of Chongqing Medical University
Mar 3, 2023
Long Covid19, COVID-19 Pneumonia, Multisystem Inflammatory Syndrome in Children Trial in Taipei (sequelae tracking)
Recruiting
- Long Covid19
- +2 more
- sequelae tracking
-
Taipei, Chung Cheng District, TaiwanNational Taiwan University Hospital
Oct 12, 2022
Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)
Not yet recruiting
- Chronic Hepatitis b
- +2 more
- Anti-PD-1 antibody
- +2 more
-
Chongqing, Chongqing, ChinaThe 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023
Respiratory Infections and Colonisation in Children Using Daily
Recruiting
- Respiratory Tract; Infection, Upper (Acute)
- Colonization, Asymptomatic
-
Hoofddorp, NetherlandsSpaarne Gasthuis
Sep 15, 2023
EMPOWER - BAME vs COVID
Withdrawn
- COVID-19, SARS-CoV 2 Infection
- Health Disparities
-
Birmingham, West Midlands, United KingdomFuture Genetics Limited
Aug 21, 2021
NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen
Not yet recruiting
- NK-T-Cell Lymphoma, Extranodal
- 4 cycles of ESA regimen with sandwiched radiotherapy
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 29, 2023
Immunodeficiency for Severe Epstein-Barr Virus Infection
Recruiting
- Epstein-Barr Virus Infections
- Immunodeficiency
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Mar 21, 2022
Circulating Biomarkers in Oropharyngeal Cancers
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- +3 more
-
Orebro, SwedenAnna Oldaeus Almerén
Jun 13, 2023
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for
Recruiting
- Nasopharyngeal Carcinoma
- EBV antibodies test
- EBV DNA test
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022
Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)
Not yet recruiting
- Pleural Mesothelioma
- Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
-
Rozzano, MI, Italy
- +5 more
Nov 30, 2023
The Gut Virome asTrigger for IBD: From Metagenomics to
Recruiting
- IBD
- Additional biopsies collection
-
Milan, ItalyIRCCS Ospedale San Raffaele
Jun 7, 2023
Treatment Optimization of Refractory
Recruiting
- Hepatitis B, Chronic
- Virus Diseases
- original therapy
- rescue therapy
-
Ankang, China
- +12 more
Feb 1, 2023
Ocular Infection, Viral Trial in Nashville
Completed
- Ocular Infection, Viral
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 22, 2022
Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)
Not yet recruiting
- Nasopharyngeal Carcinoma
- CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
-
Singapore, Singapore
- +1 more
Oct 16, 2023
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022